- Home
- COYA vs STHO Comparison
COYA vs STHO Comparison
Compare COYA & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- STHO
- Stock Information
- Founded
- COYA 2020
- STHO N/A
- Country
- COYA United States
- STHO United States
- Employees
- COYA N/A
- STHO N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- STHO Real Estate
- Sector
- COYA Health Care
- STHO Real Estate
- Exchange
- COYA Nasdaq
- STHO Nasdaq
- Market Cap
- COYA 99.8M
- STHO 89.7M
- IPO Year
- COYA 2022
- STHO N/A
- Fundamental
- Price
- COYA $5.80
- STHO $7.84
- Analyst Decision
- COYA Strong Buy
- STHO
- Analyst Count
- COYA 3
- STHO 0
- Target Price
- COYA $16.67
- STHO N/A
- AVG Volume (30 Days)
- COYA 52.1K
- STHO 198.4K
- Earning Date
- COYA 08-11-2025
- STHO 08-05-2025
- Dividend Yield
- COYA N/A
- STHO N/A
- EPS Growth
- COYA N/A
- STHO N/A
- EPS
- COYA N/A
- STHO N/A
- Revenue
- COYA $3,685,107.00
- STHO $113,297,000.00
- Revenue This Year
- COYA $106.97
- STHO N/A
- Revenue Next Year
- COYA N/A
- STHO N/A
- P/E Ratio
- COYA N/A
- STHO N/A
- Revenue Growth
- COYA N/A
- STHO N/A
- 52 Week Low
- COYA $4.65
- STHO $6.06
- 52 Week High
- COYA $10.24
- STHO $14.50
- Technical
- Relative Strength Index (RSI)
- COYA 55.18
- STHO 57.07
- Support Level
- COYA $5.61
- STHO $7.67
- Resistance Level
- COYA $5.87
- STHO $8.16
- Average True Range (ATR)
- COYA 0.37
- STHO 0.29
- MACD
- COYA 0.05
- STHO 0.03
- Stochastic Oscillator
- COYA 67.51
- STHO 50.56
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.